Researchers map out Real-World leukemia treatment paths and expenses
NCT ID NCT07150793
Summary
This study looked back at medical records to understand how doctors in Japan treat chronic myeloid leukemia (CML) with targeted drugs called TKIs. It followed 754 patients to see which drugs they used, how often they switched or stopped treatment, and what the associated healthcare costs were. The goal was to gather real-world information to better understand treatment patterns and the burden of managing this cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOID LEUKEMIA, CHRONIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis
East Hanover, New Jersey, 07936, United States
Conditions
Explore the condition pages connected to this study.